Thermo Fisher Scientific Stock

$487.53

1.05%

NYSE, Sep 02, 10:04 pm CET

ISIN

US8835561023

Symbol

TMO

Reports

Quarter | Annual

Index

NYSE Composite, S&P 500

Sector

Pharmaceuticals, Biotechnology & Life Sciences

Industry

Life Sciences Tools & Services

Overview Dividends Analysts Charts News Strategies

Thermo Fisher Scientific Stock price

$487.53

+46.47 10.54% 5Y

NYSE, Closing price Tue, Sep 02 2025

-5.19 1.05%

ISIN

US8835561023

Symbol

TMO

Reports

Quarter | Annual

Index

NYSE Composite, S&P 500

Sector

Pharmaceuticals, Biotechnology & Life Sciences

Industry

Life Sciences Tools & Services

Key metrics

Basic

Market capitalization

$184.1b

Enterprise Value

$212.9b

Net debt

$28.8b

Cash

$6.4b

Shares outstanding

377.5m

Valuation (TTM | estimate)

P/E

28.0 | 21.5

P/S

4.3 | 4.2

EV/Sales

4.9 | 4.8

EV/FCF

34.5

P/B

3.7

Dividends

DPS

$1.56

Yield 1Y | 5Y

0.3% | 0.2%

Growth 1Y | 5Y

11.4% | 15.5%

Payout 1Y | 3Y

9.4% | 8.4%

Increased

7 Years

Financials (TTM | estimate)

Revenue

$43.2b | $44.3b

EBITDA

$8.3b | $11.1b

EBIT

$7.9b | $10.0b

Net Income

$6.6b | $8.6b

Free Cash Flow

$6.2b

Growth (TTM | estimate)

Revenue

2.1% | 3.4%

EBITDA

-23.2% | 14.6%

EBIT

5.2% | 29.1%

Net Income

5.8% | 35.4%

Free Cash Flow

-22.5%

Financial Health

Equity Ratio

50.9%

Return on Equity

12.8%

ROCE

8.9%

ROIC

Debt/Equity

0.7

EPS

$17.4

FCF per Share

$16.3

Short interest

1.0%

Employees

125k

Rev per Employee

$340.0k

As a Free StocksGuide user, you can view scores for all 7,011 stocks worldwide.

Get Started for Free Today

Thermo Fisher Scientific Stock Analysis

Unlock Scores for Free

??

35 Analysts have issued a Thermo Fisher Scientific forecast:

27x Buy

77%

8x Hold

23%

More details on Analyst Estimates Including Price Targets

35 Analysts have issued a Thermo Fisher Scientific forecast:

Buy

77%

Hold

23%

Analyst Estimates with Stock Price Targets

Financial data from Thermo Fisher Scientific

Income Statement P&L | Balance Sheet | Cash Flow

Quarter TTM Annually

Jun '25		+/- %
Revenue	43,212 43,212	2% 2% 100%
- Direct Costs	25,350 25,350	1% 1% 59%
Gross Profit	17,862 17,862	3% 3% 41%
- Selling and Administrative Expenses	8,085 8,085	4% 4% 19%
- Research and Development Expense	1,414 1,414	7% 7% 3%
EBITDA	8,286 8,286	23% 23% 19%
- Depreciation and Amortization	429 429	87% 87% 1%
EBIT (Operating Income) EBIT	7,857 7,857	5% 5% 18%
Net Profit	6,584 6,584	6% 6% 15%

In millions USD.

If you wish, we will send you an e-mail every morning with news on stocks of your portfolios.

Subscribe Now

Thermo Fisher Scientific Stock News

Negative

The Motley Fool

●

about 9 hours ago

Why Thermo Fisher Scientific Stock Tumbled Today

Sprawling medical device and solutions company Thermo Fisher Scientific (TMO -1.22%) wasn't looking all that healthy on Tuesday, at least as far as its stock was concerned. The company closed a pair of acquisitions, and the twin moves didn't seem to make some investors happy.

Neutral

Business Wire

●

about 19 hours ago

Thermo Fisher Scientific Completes Acquisition of Sanofi's Ridgefield, New Jersey Site

WALTHAM, Mass.--(BUSINESS WIRE)--Thermo Fisher Scientific Inc. (NYSE:TMO), the world leader in serving science, today announced the completion of its acquisition of Sanofi's state-of-the-art sterile fill-finish and packaging site in Ridgefield, New Jersey, marking an expansion of the companies' strategic partnership to enable additional U.S. drug product manufacturing. The terms of the deal wer...

Neutral

Business Wire

●

about 20 hours ago

Thermo Fisher Scientific Completes Acquisition of Solventum's Purification and Filtration Business

WALTHAM, Mass.--(BUSINESS WIRE)--Thermo Fisher Scientific Inc. (NYSE: TMO) (“Thermo Fisher”), the world leader in serving science, today announced the completion of its acquisition of the Purification & Filtration business of Solventum (NYSE: SOLV) for approximately $4.0 billion in cash. With the transaction complete, the business, which is now Thermo Fisher's Filtration and Separation business...

More Thermo Fisher Scientific News

Company Profile

Thermo Fisher Scientific, Inc. engages in the provision of analytical instruments, equipment, reagents and consumables, software and services for research, analysis, discovery, and diagnostics. It operates through the following segments: Life Sciences Solutions, Analytical Instruments, Specialty Diagnostics, and Laboratory Products and Services. The Life Sciences Solutions segment comprises of portfolio of reagents, instruments, and consumables used in biological and medical research, discovery and production of new drugs, and vaccines as well as diagnosis of disease. The Analytical Instruments segment offers instruments, consumables, software, and services that are used for a range of applications in the laboratory, on the production line, and in the field. The Specialty Diagnostics segment gives diagnostic test kits, reagents, culture media, instruments, and associated products used to increase the speed and accuracy of diagnoses. The Laboratory Products and Services segment involves in providing everything needed for the laboratory, including a combination of self-manufactured and sourced products for customers in research, academic, government, industrial, and healthcare settings. The company was founded on October 11, 1960 and is headquartered in Waltham, MA.

Head office	United States
CEO	Marc Casper
Employees	125,000
Founded	1960
Website	www.thermofisher.com

Register for Free

StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.

Start now